• Save
Tweetroducing bioZhena In 8 Slides
Upcoming SlideShare
Loading in...5
×
 

Tweetroducing bioZhena In 8 Slides

on

  • 362 views

Tweetroducing bioZhena in 8 slides

Tweetroducing bioZhena in 8 slides

Statistics

Views

Total Views
362
Slideshare-icon Views on SlideShare
356
Embed Views
6

Actions

Likes
0
Downloads
0
Comments
0

1 Embed 6

http://www.linkedin.com 6

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • 2005/4/15
  • 2005/4/15

Tweetroducing bioZhena In 8 Slides Tweetroducing bioZhena In 8 Slides Presentation Transcript

  • Private Placement Offering and/or Strategic Alliance Proposal September 2011 09/02/11 bioZhena Corporation
  • Target Customers’ Profile 30% Sub-fertile 70% Birth control 100% Cervical health cancer, STDs Three statistics tell the story Personalized medicine - diagnostic tools $232 Billion personalized medicine market to grow 11% annually said PricewaterhouseCoopers
  • 70% of women “would switch” 70% of women who would buy the Ovulona Smart Sensor, would switch from their current birth control to our fertility status monitor [from a survey of 5,000 US women]
  • Cervical Cancer Screen Innocuous affordable triage for colposcopy-biopsy As the sensor monitors cervical tissues, other STIs will have specific signatures. Through the HPO axis, other gynecological cancers may become detectable. Billions women globally. Tens of millions reproductive-age women in the U.S. alone. This screen is for everyone. Affordable. Private. Solid.
  • Friendly Technology From Home to Healthcare Providers From patients’ Ovulona™ units to physician’s Ovulograph™ – when needed
  • Applications, apps Helping to Conceive Pregnancy Managing Menstrual Cycle Natural Birth Control Managing Menopause Cervical Cancer, STD Screening
  • Total Available Market 09/02/11 bioZhena Corporation Cervical cancer screening is an estimated annual $5B US Pap smear test market. Worldwide extrapolation: >$100B annually. Ovulona™ will save an est. 50% - 90%. Segments of bioZhena’s target market: Trying to Conceive Pregnancy Market Managing Menstrual Cycle Market Birth Control Market Managing Menopause Market Cervical Health Screening Market U.S. ~$ 25B World >$500B
  • bioZhena Corporation’s Offering Personalized Health Management Contact vaclavkirsner@yahoo.com